Lyophilised dabigatran

Details for Australian Patent Application No. 2010209804 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Stangier, Joachim

Agent Spruson & Ferguson

Pub. Number AU-A-2010209804

PCT Pub. Number WO2010/086329

Priority 09151865.4 02.02.09 EP

Filing date 27 January 2010

Wipo publication date 5 August 2010

International Classifications

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

G01N 33/96 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood or serum control standard

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/086329 Priority application(s): WO2010/086329

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209806-Composition comprising caftaric acid and/or derivatives thereof

2010209801-Method and apparatus for diagnosing a diseased condition in tissue of a subject